Scientific Presentations

All - Archived Presentations
Date Presentation Details
Feb 23, 2017
Presentation at the American Society of Clinical Oncology (ASCO) - Society for Immunotherapy of Cancer (SITC) Clinical Immuno-Oncology Symposium by Khursheed Anwer, Ph.D. (Celsion's executive vice president and chief science officer) entitled "Immunological changes following intraperitoneal administration of a formulated IL-12 plasmid in combination with standard neoadjuvant chemotherapy in patients with newly diagnosed advanced stage ovarian cancer."
Feb 23, 2017
Presentation at the American Society of Clinical Oncology (ASCO) - Society for Immunotherapy of Cancer (SITC) Clinical Immuno-Oncology Symposium by Khursheed Anwer, Ph.D. (Celsion's executive vice president and chief science officer) entitled "Phase I study and activity of formulated IL-12 plasmid administered intraperitoneally in combination with standard neoadjuvant chemotherapy in patients with newly diagnosed advanced stage ovarian cancer."
Nov 28, 2016
Presentation at the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, IL by Dr. Haydar Celik, Ph.D. (NIH Clinical Center) entitled "RFA Duration per Tumor Volume May Correlate With Overall Survival in Patients Treated with RFA plus Lyso Thermosensitive Liposomal Doxorubicin (LTLD)"
Oct 29, 2016
Presentation at the 3rd Asian Conference on Tumor Ablation (ACTA) in Seoul, Korea by Professor Won Young Tak, M.D., Ph.D. entitled "Thermo-Sensitive Drug Assisted Ablation.
Apr 18, 2016
Presentation at the 2016 American Association of Cancer Research (AACR) Annual Meeting during the Drug Delivery Session by Dr. Jason Fewell entitled "Interlukin-12 Gene therapy in Combination with Bevacizumab and PEGylated Liposomal Doxorubicin for Treatment of Disseminated Ovarian Cancer."
Dec 14, 2015
Presentation at the 2015 San Antonio Breast Cancer Symposium during the New Drugs and Treatment Strategies Session by Dr. Hope Rugo entitled Lyso-Thermosensitive Liposomal Doxorubicin Shows Efficacy with Minimal Adverse Events in Patients with Breast Cancer Recurrence at the Chest Wall.
Nov 2, 2015
Presentation Abstracts and Oral Presentation from the 2015 Asian Conference on Tumor Ablation (ACTA) in Fukuoka, Japan on October 30-31, 2015
Sep 5, 2015
Presentation at the International Liver Cancer Association 2015 Annual Conference on September 5, 2015 by Dr. Ghassan K. Abou-Alfa entitled "Intermediate HCC Treatment Paradigms and Lessons Learned."
Sep 5, 2015
Presentation at the International Liver Cancer Association 2015 Annual Conference on September 5, 2015 by Professor Riccardo Lencioni entitled "OPTIMA Phase III Clinical Trial: Study Design and Protocol."
Sep 5, 2015
Presentation at the International Liver Cancer Association 2015 Annual Conference on September 5, 2015 by Dr. Ronnie T.P. Poon entitled ""Current Management of Intermediate HCC: Unmet Medical Needs."
Jun 1, 2015
A Phase I Study of Intraperitoneal EGEN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer) Administered in Combination with Pegylated Liposomal Doxorubicin) in Patients with Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Feb 20, 2015
Presentation at the Molecular Medicine TRI-Conference on February 20, 2015 by Dr. Khursheed Anwer titled "Development of a Novel IL-12 DNA-based Immunotherapy in Combination with Chemotherapy for Treatment of Advanced Ovarian Cancer."
Sep 6, 2014
Presentation at the International Liver Cancer Association 2014 Annual Conference on September 6, 2014 by Professor Riccardo Lencioni titled "Image Guided Ablations: Current Status and Future Prospects"
Sep 6, 2014
Presentation at the International Liver Cancer Association 2014 Annual Conference on September 6, 2014 by Dr. Richard Finn titled "Phase III Studies in Intermediate Stage HCC: What Have We Learned From Recent Failures"
Sep 6, 2014
Presentation at the International Liver Cancer Association 2014 Annual Conference on September 6, 2014 by Professor Ronnie T.P. Poon titled "New Paradigms in Staging HCC: BCLC vs. Hong Kong Liver Cancer Staging System (HKLS)"
Apr 9, 2014
Presentation at the 14th Annual Symposium on Therapeutic Ultrasound in Las Vegas, NV on April 5, 2014 by Dr. Mark Dewhirst – "Use of Thermosensitive Liposomes in Combination with Ultrasound"
Dec 12, 2013
Novel Targeted Therapy for Breast Cancer Chest Wall Recurrence Poster Presentation by Prof Hope S. Rugo, MD at the 2013 San Antonio Breast Cancer Conference.
Sep 16, 2013
Presentation at the 2013 International Liver Cancer Association (ILCA) Conference on September 14, 2013 by Professor Ronnie T.P. Poon, MD, PhD.
Jun 20, 2013
Presentation at The European Conference on Interventional Oncology (ECIO) by Professor Riccardo Lencioni, MD "New IO Approaches for HCC: An Update on Clinical Trials"
Jun 20, 2013
Presentation at The European Conference on Interventional Oncology (ECIO) by Professor Riccardo Lencioni, MD New Horizons: Thermally Sensitive Doxorubicin Carriers
May 16, 2013
Presentation at the World Conference on Interventional Oncology (WCIO) By Professor Riccardo Lencioni, MD "Advances in Image-Guided Ablation"
May 16, 2013
Presentation at the World Conference on Interventional Oncology (WCIO) By Professor Ronnie T.P.Poon, MD, PhD "Thermally Sensitive Drug Carriers In Combination with Thermal Ablation"
Sep 17, 2012
Presentation at the 2012 Annual Congress of the Cardiovascular and Interventional Radiological Society of Europe by Professor Ronnie T.P. Poon "Thermosensitive Liposome in Combination with Thermal Ablation"
= add file to Briefcase
Share This